Company Description
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.
As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle.
Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects.
Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success.
Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform.
We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
| Country | United States |
| IPO Date | May 27, 1997 |
| Industry | REIT - Office |
| Sector | Real Estate |
| Employees | 568 |
| CEO | Peter M. Moglia |
Contact Details
Address: 26 North Euclid Avenue Pasadena, California 91101 United States | |
| Phone | (626) 578-0777 |
| Website | are.com |
Stock Details
| Ticker Symbol | ARE |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001035443 |
| CUSIP Number | 015271109 |
| ISIN Number | US0152711091 |
| Employer ID | 95-4502084 |
| SIC Code | 6798 |
Key Executives
| Name | Position |
|---|---|
| Joel S. Marcus CPA, J.D. | Founder and Executive Chairman |
| Peter M. Moglia | Chief Executive Officer and Chief Investment Officer |
| Daniel J. Ryan | Co-President and Regional Market Director of San Diego |
| Hunter L. Kass | Co-President and Regional Market Director of Greater Boston |
| Marc E. Binda | Chief Financial Officer and Treasurer |
| Vincent R. Ciruzzi Jr. | Chief Development Officer |
| Dean A. Shigenaga CPA | Strategic Consultant |
| Lawrence J. Diamond | Co-Chief Operating Officer and Regional Market Director of Maryland |
| Joseph Hakman | Co-Chief Operating Officer and Chief Strategic Transactions Officer |
| Andres R. Gavinet CPA | Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2024 | 8-K | Current Report |
| Apr 22, 2024 | 10-Q | Quarterly Report |
| Apr 3, 2024 | ARS | Filing |
| Apr 3, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 13, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Feb 26, 2024 | 144 | Filing |
| Feb 15, 2024 | 8-K | Current Report |
| Feb 15, 2024 | 424B5 | Filing |
| Feb 15, 2024 | 8-K | Current Report |